vs

Side-by-side financial comparison of CAMDEN NATIONAL CORP (CAC) and PETMED EXPRESS INC (PETS). Click either name above to swap in a different company.

CAMDEN NATIONAL CORP is the larger business by last-quarter revenue ($64.3M vs $40.7M, roughly 1.6× PETMED EXPRESS INC). CAMDEN NATIONAL CORP runs the higher net margin — 34.0% vs -26.0%, a 60.0% gap on every dollar of revenue. Over the past eight quarters, CAMDEN NATIONAL CORP's revenue compounded faster (22.6% CAGR vs -20.9%).

Camden National Bank is a commercial bank headquartered in Camden, Maine, operating as the principal subsidiary of Camden National Corporation, a publicly traded bank holding company. Founded in 1875, the bank became a direct, wholly owned subsidiary of the holding company following a corporate reorganization in 1984. Following the 2025 merger with Northway Financial, the combined institution has approximately $7.0 billion in assets.

PetMed Express, Inc., also known as PetMeds, is an online pet pharmacy based in the United States. It is publicly traded and sells prescription and non-prescription pet medication.

CAC vs PETS — Head-to-Head

Bigger by revenue
CAC
CAC
1.6× larger
CAC
$64.3M
$40.7M
PETS
Higher net margin
CAC
CAC
60.0% more per $
CAC
34.0%
-26.0%
PETS
Faster 2-yr revenue CAGR
CAC
CAC
Annualised
CAC
22.6%
-20.9%
PETS

Income Statement — Q1 FY2026 vs Q3 FY2026

Metric
CAC
CAC
PETS
PETS
Revenue
$64.3M
$40.7M
Net Profit
$21.9M
$-10.6M
Gross Margin
23.3%
Operating Margin
-25.7%
Net Margin
34.0%
-26.0%
Revenue YoY
-23.3%
Net Profit YoY
-1392.6%
EPS (diluted)
$1.29
$-0.50

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CAC
CAC
PETS
PETS
Q1 26
$64.3M
Q4 25
$68.1M
$40.7M
Q3 25
$65.4M
$44.4M
Q2 25
$62.3M
$51.2M
Q1 25
$60.1M
$50.8M
Q4 24
$47.6M
$52.0M
Q3 24
$45.0M
$58.0M
Q2 24
$42.8M
$66.2M
Net Profit
CAC
CAC
PETS
PETS
Q1 26
$21.9M
Q4 25
$22.6M
$-10.6M
Q3 25
$21.2M
$-8.5M
Q2 25
$14.1M
$-34.2M
Q1 25
$7.3M
$-11.6M
Q4 24
$14.7M
$-707.0K
Q3 24
$13.1M
$2.3M
Q2 24
$12.0M
$3.8M
Gross Margin
CAC
CAC
PETS
PETS
Q1 26
Q4 25
23.3%
Q3 25
28.0%
Q2 25
28.1%
Q1 25
29.9%
Q4 24
31.0%
Q3 24
32.3%
Q2 24
28.8%
Operating Margin
CAC
CAC
PETS
PETS
Q1 26
Q4 25
41.5%
-25.7%
Q3 25
40.5%
-18.9%
Q2 25
28.5%
-66.7%
Q1 25
10.3%
-11.9%
Q4 24
38.7%
-0.9%
Q3 24
35.2%
1.0%
Q2 24
34.7%
6.6%
Net Margin
CAC
CAC
PETS
PETS
Q1 26
34.0%
Q4 25
33.1%
-26.0%
Q3 25
32.4%
-19.2%
Q2 25
22.6%
-66.7%
Q1 25
12.2%
-22.9%
Q4 24
30.8%
-1.4%
Q3 24
29.1%
4.0%
Q2 24
28.0%
5.7%
EPS (diluted)
CAC
CAC
PETS
PETS
Q1 26
$1.29
Q4 25
$1.33
$-0.50
Q3 25
$1.25
$-0.41
Q2 25
$0.83
$-1.65
Q1 25
$0.43
$-0.56
Q4 24
$1.00
$-0.03
Q3 24
$0.90
$0.11
Q2 24
$0.81
$0.18

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CAC
CAC
PETS
PETS
Cash + ST InvestmentsLiquidity on hand
$26.9M
Total DebtLower is stronger
$514.4M
Stockholders' EquityBook value
$710.0M
$32.8M
Total Assets
$7.0B
$88.0M
Debt / EquityLower = less leverage
0.72×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CAC
CAC
PETS
PETS
Q1 26
Q4 25
$26.9M
Q3 25
$36.1M
Q2 25
$41.1M
Q1 25
$54.7M
Q4 24
$50.1M
Q3 24
$52.0M
Q2 24
$46.0M
Total Debt
CAC
CAC
PETS
PETS
Q1 26
$514.4M
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Stockholders' Equity
CAC
CAC
PETS
PETS
Q1 26
$710.0M
Q4 25
$696.6M
$32.8M
Q3 25
$676.4M
$43.1M
Q2 25
$652.1M
$51.5M
Q1 25
$640.1M
$85.1M
Q4 24
$531.2M
$96.2M
Q3 24
$529.9M
$96.4M
Q2 24
$508.3M
$93.5M
Total Assets
CAC
CAC
PETS
PETS
Q1 26
$7.0B
Q4 25
$7.0B
$88.0M
Q3 25
$7.0B
$100.3M
Q2 25
$6.9B
$109.8M
Q1 25
$7.0B
$148.7M
Q4 24
$5.8B
$144.8M
Q3 24
$5.7B
$146.0M
Q2 24
$5.7B
$152.7M
Debt / Equity
CAC
CAC
PETS
PETS
Q1 26
0.72×
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CAC
CAC
PETS
PETS
Operating Cash FlowLast quarter
$-9.2M
Free Cash FlowOCF − Capex
$-9.2M
FCF MarginFCF / Revenue
-22.7%
Capex IntensityCapex / Revenue
0.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-23.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CAC
CAC
PETS
PETS
Q1 26
Q4 25
$63.9M
$-9.2M
Q3 25
$36.1M
$-2.2M
Q2 25
$6.0M
$-12.3M
Q1 25
$1.0M
$7.0M
Q4 24
$60.9M
$-1.2M
Q3 24
$-14.5M
$7.4M
Q2 24
$14.5M
$-8.5M
Free Cash Flow
CAC
CAC
PETS
PETS
Q1 26
Q4 25
$58.2M
$-9.2M
Q3 25
$35.4M
$-4.8M
Q2 25
$4.5M
$-13.6M
Q1 25
$-727.0K
$4.6M
Q4 24
$55.4M
$-1.9M
Q3 24
$-16.2M
$6.1M
Q2 24
$13.2M
$-9.2M
FCF Margin
CAC
CAC
PETS
PETS
Q1 26
Q4 25
85.5%
-22.7%
Q3 25
54.1%
-10.8%
Q2 25
7.3%
-26.5%
Q1 25
-1.2%
9.1%
Q4 24
116.4%
-3.7%
Q3 24
-36.0%
10.6%
Q2 24
30.8%
-13.9%
Capex Intensity
CAC
CAC
PETS
PETS
Q1 26
Q4 25
8.4%
0.1%
Q3 25
1.1%
5.9%
Q2 25
2.4%
2.5%
Q1 25
2.9%
4.7%
Q4 24
11.7%
1.5%
Q3 24
3.8%
2.2%
Q2 24
3.0%
1.0%
Cash Conversion
CAC
CAC
PETS
PETS
Q1 26
Q4 25
2.83×
Q3 25
1.70×
Q2 25
0.43×
Q1 25
0.14×
Q4 24
4.15×
Q3 24
-1.11×
3.18×
Q2 24
1.21×
-2.27×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CAC
CAC

Net Interest Income$52.4M81%
Noninterest Income$12.0M19%

PETS
PETS

Reorder$34.0M84%
New Order$5.0M12%
Membership Fees$1.6M4%

Related Comparisons